Antirejection drugs and procedures.
D000477:Alkylating Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004322:Drainage; D006084:Graft Rejection / Q000187:drug effects*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013897:Thoracic Duct; D014184:Transplantation, Homologous
D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone